We show here that lucanthone targeted glioma cells CD133+ glioma cells that have acquired resistance to TMZ, recapitulating previous reports that temozolomide induces glioma cells to acquire more stem-like characteristics (47). This evidence concerns the gene PROM1 and central nervous system cancer.